摘要
目的探讨非高密度脂蛋白胆固醇与2型糖尿病微血管并发症的关系及临床价值。方法选择2型糖尿病患者120例,并将其分为糖尿病无血管并发症组60例(B组)和糖尿病微血管并发症组60例(c组),另选择正常对照组100例(A组),检测各组血脂并计算非高密度脂蛋白胆固醇(non-HDL—C)。结果A组、B组、C组non—HDL—C水平依次升高,且差异有统计学意义(P〈0.05);运用ROC曲线对B组、C组的血脂指标进行分析显示,non—HDL—C的曲线下面积最大,为0.638,且两组间比较差异有统计学意义(P〈0.05),临床应用价值较大。结论non—HDL—C的增高是糖尿病微血管并发症的危险因素,有较高的临床应用价值。
Objective To explore the relationship of non-HDL-C and microvascular complications with type 2 diabetes mellitus and analyze the clinical application value of non-HDL-C. Methods 120 patients with T2DM were enrolled in the study:60 patients without mirovascular complications (group B), 60 patients with microvascular complications ( group C ), meanwhile 100 individuals as normal controls ( group A). Blood lipids were measured and non-HDL-C was calculated. Results The level of non-HDL-C was successively increased in group A, B and C, and there was significant difference among these three groups (P 〈 0.05) ; Using ROC curve to analyze the clinical application value of non-HDL-C in patients with microvascular complications of T2DM, we found that compared with group B, non-HDL-C had the largest area undercurve of 0.638 in group C and had significant difference ( P 〈 0.05 ). Conclusion The increase of non- HDL-C was the risk factor for microascular complications of T2DM and had high clinical application value.
出处
《临床内科杂志》
CAS
2010年第2期99-101,共3页
Journal of Clinical Internal Medicine